C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 487/04 (2006.01) A61K 31/505 (2006.01)
Patent
CA 2148324
The invention relates to the use of the compounds mentioned below in the therapeutic treatment of tumour diseases and other proliferative diseases, such as psoriasis, and to novel compounds of that type. The compounds are compounds of formula I Image (I) wherein n is from 0 to 5 and, when n is not 0, R is one or more substituents selected from halogen, alkyl, trifluoromethyl and alkoxy; and R1 and R2 are each independently of the other alkyl, or phenyl that is unsubstituted or substituted by halogen, trifluoromethyl, alkyl or by alkoxy, it also being possible for one of the two radicals R1 and R2 to be hydrogen, or R1 and R2 together form an alkylene chain having from 2 to 5 carbon atoms that is unsubstituted or substituted by alkyl; or salts thereof. Compounds of formula I inhibit protein kinases, for example the tyrosine protein kinase of the receptor for the epidermal growth factor, EGF.
Brill Wolfgang K.-D.
Furet Pascal
Traxler Peter
Fetherstonhaugh & Co.
Novartis Ag
LandOfFree
Pyrrolopyrimidine derivatives having pharmacological activity does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pyrrolopyrimidine derivatives having pharmacological activity, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pyrrolopyrimidine derivatives having pharmacological activity will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1720122